The clinical utility of genome-wide non invasive prenatal screening

Prenatal Diagnosis

Volumn 37, Issue 6, 2017, Pages 593-601

  Fiorentino, Francesco ^a   Bono, Sara ^a   Pizzuti, Francesca ^a   Duca, Sara ^a   Polverari, Arianna ^a   Faieta, Monica ^a   Baldi, Marina ^a   Diano, Laura ^a   Spinella, Francesca ^a  

^a GENOMA Molecular Genetics Laboratory   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA;

ADULT; ANEUPLOIDY; ARTICLE; CELL FREE SYSTEM; CHROMOSOME ABERRATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA SCREENING; FEMALE; GENE SEQUENCE; GENETIC ALGORITHM; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NON INVASIVE MEASUREMENT; PREGNANT WOMAN; PRENATAL SCREENING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; CLINICAL TRIAL; COPY NUMBER VARIATION; HUMAN GENOME; MATERNAL SERUM SCREENING TEST; MIDDLE AGED; PREGNANCY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; CHROMOSOME ABERRATIONS; DNA COPY NUMBER VARIATIONS; FEMALE; GENOME, HUMAN; HUMANS; MATERNAL SERUM SCREENING TESTS; MIDDLE AGED; PREGNANCY; YOUNG ADULT;

EID: 85018900935     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.5053     Document Type: Article

References (36)

1. Chitty LS, Bianchi DW. Noninvasive prenatal testing: the paradigm is shifting rapidly. Prenat Diagn 2013;33:511–513.
2. Zhang H, Gao Y, Jiang F, et al. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies. Ultrasound Obstet Gynecol 2015;45:530–538.
3. McCullough RM, Almasri EA, Guan X, et al. Non-invasive prenatal chromosomal aneuploidy testing–clinical experience: 100,000 clinical samples. PLoS One 2014;9:e109173.
4. Taneja PA, Snyder HL, de Feo E, et al. Noninvasive prenatal testing in the general obstetric population: clinical performance and counseling considerations in over 85 000 cases. Prenat Diagn 2016;36:237–243.
5. Gil MM, Quezada MS, Revello R, et al. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol 2015;45:249–266.
6. Mackie FL, Hemming K, Allen S, et al. The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis. BJOG 2017;124:32–46.
7. Taylor-Phillips S, Freeman K, Geppert J, et al. Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis. BMJ Open 2016;18:e010002.
8. Gregg AR, Skotko BG, Benkendorf JL, et al. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics. Genet Med 2016;18:1056–1065.
9. Committee Opinion No. 640: Cell-free DNA screening for fetal aneuploidy. Obstet Gynecol 2015;126:e31–e37.
10. Society for Maternal–Fetal Medicine (SMFM) Publications Committee #36: Prenatal aneuploidy screening using cell-free DNA. Am J Obstet Gynecol 2015;212:711–716.
11. Benn P, Borrell A, Chiu RW, et al. Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn 2015;35:725–734.
12. Dondorp W, de Wert G, Bombard Y, et al. Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Summary and recommendations. Eur J Hum Genet 2015;23:1592.
13. Wellesley D, Dolk H, Boyd PA, et al. Rare chromosome abnormalities, prevalence and prenatal diagnosis rates from population-based congenital anomaly registers in Europe. Eur J Hum Genet 2012;20:521–526.
14. Peters D, Chu T, Yatsenko SA, et al. Noninvasive prenatal diagnosis of a fetal microdeletion syndrome. N Engl J Med 2011;365:1847–1848.
15. Jensen TJ, Dzakula Z, Deciu C, et al. Detection of microdeletion 22q11.2 in a fetus by next-generation sequencing of maternal plasma. Clin Chem 2012;58:1148–1151.
16. Wapner RJ, Babiarz JE, Levy B, et al. Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes. Am J Obstet Gynecol 2015;212:332.e1–332.e9.
17. Srinivasan A, Bianchi DW, Huang H, et al. Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J hum Genet 2013;92:167–176.
18. Yu SC, Jiang P, Choy KW et al. Noninvasive prenatal molecular karyotyping from maternal plasma. PLoS One 2013;8:e60968.
19. Chen S, Lau TK, Zhang C, et al. A method for noninvasive detection of fetal large deletions/duplications by low coverage massively parallel sequencing. Prenat Diagn 2013;33:584–590.
20. Straver R, Sistermans EA, Holstege H, et al. WISECONDOR: detection of fetal aberrations from shallow sequencing maternal plasma based on a within-sample comparison scheme. Nucleic Acids Res 2014;42:e31.
21. Bayindir B, Dehaspe L, Brison N, et al. Noninvasive prenatal testing using a novel analysis pipeline to screen for all autosomal fetal aneuploidies improves pregnancy management. Eur J Hum Genet 2015;23:1286–1293.
22. Zhao C, Tynan J, Ehrich M, et al. Detection of fetal subchromosomal abnormalities by sequencing circulating cell-free DNA from maternal plasma. Clin Chem 2015;61:608–616.
23. Yin AH, Peng CF, Zhao X, et al. Noninvasive detection of fetal subchromosomal abnormalities by semiconductor sequencing of maternal plasma DNA. Proc Natl Acad Sci U S A 2015;112:14670–14675.
24. Pescia G, Guex N, Iseli C, et al. Cell-free DNA testing of an extended range of chromosomal anomalies: clinical experience with 6,388 consecutive cases. Genet Med 2016. https://doi.org/10.1038/gim.2016.72.
25. Lefkowitz RB, Tynan JA, Liu T, et al. Clinical validation of a noninvasive prenatal test for genomewide detection of fetal copy number variants. Am J Obstet Gynecol 2016;(215):227.e1–227.e16.
26. Snyder MW, Gammill HS, Shendure J. Copy-number variation and false positive results of prenatal screening. N Engl J Med 2015;373:2583–2585.
27. Chudova DI, Sehnert AJ, Bianchi DW. Copy-number variation and false positive prenatal screening results. N Engl J Med 2016;375:97–98.
28. Fiorentino F, Bono S, Pizzuti F, et al. The importance of determining the limit of detection of non-invasive prenatal testing methods. Prenat Diagn 2016;36:304–311.
29. Li H, Durbin R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics 2009;25:1754–1760.
30. Mersy E, Faas BH, Spierts S, et al. Cell-free RNA is a reliable fetoplacental marker in noninvasive fetal sex determination. Clin Chem 2015;61:1515–1523.
31. Clopper C, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 1934;26:404–413.
32. Lestou VS, Kalousek DK. Confined placental mosaicism and intrauterine fetal growth. Arch dis Child Fetal Neonatal Ed 1998;79:F223–F226.
33. Wilkins-Haug L, Quade B, Morton CC. Confined placental mosaicism as a risk factor among newborns with fetal growth restriction. Prenat Diagn 2006;26:428–432.
34. Robinson WP, Peñaherrera MS, Jiang R, et al. Assessing the role of placental trisomy in preeclampsia and intrauterine growth restriction. Prenat Diagn 2010;30:1–8.
35. Wolstenholme J, Rooney DE, Davison EV. Confined placental mosaicism, IUGR, and adverse pregnancy outcome: a controlled retrospective U.K. collaborative survey. Prenat Diagn 1994;14:345–361.
36. Eggermann T, Soellner L, Buiting K, et al. Mosaicism and uniparental disomy in prenatal diagnosis. Trends Mol Med 2015;21:77–87.